Candriam S.C.A. - PIERIS PHARMACEUTICALS INC ownership

PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 85 filers reported holding PIERIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Candriam S.C.A. ownership history of PIERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$316,066
-67.7%
351,834
-62.6%
0.00%
-71.4%
Q4 2022$979,461
-19.8%
941,834
-11.3%
0.01%
-22.2%
Q3 2022$1,221,000
-38.5%
1,061,8340.0%0.01%
-43.8%
Q2 2022$1,986,000
-38.3%
1,061,8340.0%0.02%
-27.3%
Q1 2022$3,217,000
-19.9%
1,061,8340.0%0.02%
-15.4%
Q4 2021$4,014,000
-26.9%
1,061,8340.0%0.03%
-29.7%
Q3 2021$5,489,000
+35.0%
1,061,8340.0%0.04%
+32.1%
Q2 2021$4,067,000
-25.5%
1,061,834
-53.3%
0.03%
-37.8%
Q1 2021$5,458,000
-3.9%
2,272,727
-0.0%
0.04%0.0%
Q4 2020$5,682,000
+18.9%
2,272,731
-1.5%
0.04%0.0%
Q3 2020$4,777,000
-34.3%
2,307,814
-1.6%
0.04%
-41.6%
Q2 2020$7,271,000
+38.1%
2,345,468
+57.6%
0.08%
+32.8%
Q1 2020$5,266,000
-2.2%
1,488,175
+0.0%
0.06%0.0%
Q4 2019$5,387,000
+139.3%
1,488,069
+125.5%
0.06%
+93.3%
Q3 2019$2,251,000660,0000.03%
Other shareholders
PIERIS PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Lynx1 Capital Management LP 1,136,319$3,443,0003.20%
Aquilo Capital Management, LLC 3,708,882$11,238,0001.65%
Soleus Capital Management, L.P. 4,134,868$12,529,0001.62%
GREAT POINT PARTNERS LLC 2,199,076$6,663,0001.61%
BVF INC/IL 5,328,239$16,145,0000.65%
Cutter & CO Brokerage, Inc. 406,229$1,231,0000.37%
WEALTH EFFECTS LLC 80,400$244,0000.11%
PLATINUM INVESTMENT MANAGEMENT LTD 1,028,322$3,116,0000.10%
Rhenman & Partners Asset Management AB 300,000$909,0000.09%
Woodline Partners LP 1,587,475$4,810,0000.08%
View complete list of PIERIS PHARMACEUTICALS INC shareholders